Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma

Vismodegib is indicated for the treatment of advanced or metastatic basal cell carcinoma (BCC). The predictive factors of response to vismodegib have so far been poorly described.

Mots clés

basal cell carcinoma Gorlin syndrome hedgehog pathway inhibitor long-term vismodegib

Domaines

Médecine humaine et pathologie

Dépôt NantesU M : Connectez-vous pour contacter le contributeur

https://nantes-universite.hal.science/hal-04758367

Soumis le : mardi 29 octobre 2024-13:41:31

Dernière modification le : jeudi 31 octobre 2024-03:21:17

Dates et versions

hal-04758367 , version 1 (29-10-2024)

Identifiants

HAL Id : hal-04758367 , version 1
DOI : 10.1684/ejd.2022.4264
PUBMED : 36065537

Citer

Cécile Juzot, Anne Isvy-Joubert, Amir Khammari, Anne-Chantal Knol, Jean-Michel Nguyen, et al.. Predictive factors of response to vismodegib: a French study of 61 patients with multiple or locally advanced basal cell carcinoma. European Journal of Dermatology, 2022, 32 (3), pp.401-407. ⟨10.1684/ejd.2022.4264⟩. ⟨hal-04758367⟩

Exporter

BibTeX XML-TEI Dublin Core DC Terms EndNote DataCite

Collections

CNRS UNIV-ANGERS CRCI2NA NANTES-UNIVERSITE UFR-MEDECINE-NANTES

5 Consultations

0 Téléchargements